Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
XRP falls by 15%, but long-term price forecast remains optimistic

XRP falls by 15%, but long-term price forecast remains optimistic

Bitget2024/01/29 15:06
Despite XRP falling by 15% in the past month, hovering around $0.52, some analysts and institutions remain confident in its future value. The Czech cryptocurrency exchange Changelly predicts that the price of XRP could rise to over $0.65 by the end of January, reach $0.72 on February 1st, then start to fall, dropping to $0.55 by February 27th. Changelly is very optimistic about long-term performance, predicting that the price of XRP will be $1.25, $1.84 and $2.70 respectively in the next three years. In addition, they predict that by 2050, the price of XRP will reach an astonishing $594.
 
Twitter user Dark Defender stated that XRP successfully broke through resistance at $.5286 in recent days indicating a potential short-term increase to $.60 and further rising towards a Fibonacci target of $1.88. Furthermore EGRAG CRYPTO predicts that XRP's price may surge to as high as$1:40 this April before setting a new historical high at five dollars. It's worth noting Ripple plans for a significant trial with US Securities Exchange Commission (SEC) on April 23rd which could impact both prices for XPR and trends within entire cryptocurrency market.
1
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD

Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.

智通财经2026/09/21 07:16

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11

Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential

According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.

智通财经2026/09/21 07:11

Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.

TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).

智通财经2026/09/21 07:11